In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols

Fertility and Sterility

Volumn 91, Issue 2, 2009, Pages 377-382

  Farhi, Jacob ^a   Ben Haroush, Avi ^a   Lande, Yehezkel ^a   Sapir, Onit ^a   Pinkas, Haim ^a   Fisch, Benjamin ^a  

^a Helen Schneider Hospital for Women   (Israel)

Author keywords

Coasting; GnRH agonist; GnRH antagonist; IVF

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ENDOMETRIN; ESTROGEN; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; PROSTAGLANDIN E2; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; HUMAN CELL; OOCYTE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; CHORIONIC GONADOTROPIN; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MENOTROPINS; OOCYTE RETRIEVAL; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIPTORELIN;

EID: 59449103463     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.11.086     Document Type: Article

References (18)

1. Sher G., Zouves C., Feinman M., and Maassarani G. Prolonged coasting: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 10 (1995) 3107-3109
2. Benadiva C.A., Davis O., Klingman I., Moomjy M., Liu H.C., and Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 67 (1997) 724-727
3. Delvigne A., and Rozenberg S. Preventive attitude of physicians to avoid OHSS in IVF patients. Hum Reprod 16 (2001) 2491-2495
4. D'Angelo A., and Amson N. "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 3 (2002) CD002811
5. Chen D., Burmeister L., Goldschlag D., and Rosenwaks Z. Ovarian hyperstimulation syndrome (strategies for prevention). Reprod Biomed Online 7 (2003) 43-49
6. Garcia-Velasco J.A., Isaza V., Quea G., and Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?. Fertil Steril 85 (2006) 547-554
7. Garcia-Velasco J.A., Zuniqa A., Pacheco A., Gomez R., Simon C., Remohi J., et al. Coasting acts through downregulation of VEGF gene expression and protein secretion. Hum Reprod 19 (2004) 1530-1538
8. Ulug U., Ben-Shlomo I., and Bahceci M. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian hyperstimulation for assisted reproduction. Fertil Steril 82 (2004) 338-342
9. Mansour R., Aboulghar M., Serour G., Amin Y., and Abou-Setta A.M. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod 20 (2005) 3167-3172
10. Kovacs P., Matyas S., and Kaali S.G. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders. Fertil Steril 85 (2006) 913-917
11. Delvigne A., Carlier C., and Rozenberg S. Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?. Fertil Steril 76 (2001) 844-846
12. Fatemi H.M., Platteau P., Albano C., Van Steirteghem A., and Devroey P. Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction. Reprod Biomed Online 5 (2002) 273-275
13. Bahceci M., Ulug U., Tosun S., Erden H.F., and Bayazit N. Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril 85 (2006) 1523-1525
14. Staessen C., Camus M., Bollen N., Devroey P., and Van-Steirteghem A.C. The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil Steril 3 (1992) 626-630
15. Tortoriello D.V., McGovern P.G., Colon J.M., Skurnick J.H., Lipetz K., and Santoro N. "Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steril 69 (1998) 454-460
16. Isaza V., Garcia-Velasco J.A., Aragones M., Remhi J., Simon C., and Pellicer A. Oocyte and embryo quality after coasting: the experience from oocyte donation. Hum Reprod 17 (2002) 1777-1782
17. Delvigne A., Kostyla K., Murillo D., Van Hoeck J., and Rozenbers S. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome. Int J Fertil Womens Med 48 (2003) 25-31
18. Levinsohn-Tavor O., Friedler S., Schachter M., Raziel A., Strassburger D., and Ron-El R. Coasting-what is the best formula?. Hum Reprod 18 (2003) 937-940